(Q34375765)

English

A controlled trial of high dose interferon, alone and after prednisone withdrawal, in the treatment of chronic hepatitis B: long term follow up

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

A controlled trial of high dose interferon, alone and after prednisone withdrawal, in the treatment of chronic hepatitis B: long term follow up (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

V Perez

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

J Findor

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

H Tanno

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

J Sordá

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

1 January 1993

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

2 Suppl

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

S91-4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Recombinant leukocyte a interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374020

6 July 2018

Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374020

6 July 2018

Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374020

6 July 2018

Interferon therapy of complicated hepatitis B virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374020

6 July 2018

Treatment of chronic hepatitis B with interferon: experience in Asian patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374020

6 July 2018

Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374020

6 July 2018

Treatment of chronic hepatitis B with interferon: experience in western countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374020

6 July 2018

Ursodeoxycholic acid treatment for chronic cholestatic liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374020

6 July 2018

Alpha-interferon therapy of chronic hepatitis B. Current status and recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1374020

6 July 2018

Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/8314497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic histologic and immunohistochemical changes in chronic hepatitis B after prolonged clearance of hepatitis B e antigen and hepatitis B surface antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/8314497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/8314497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term remission of chronic hepatitis B after alpha-interferon therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8314497

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/GUT.34.2_SUPPL.S91

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34375765&oldid=1590368296"